CRIPTO3 and breast cancer: We revealed a progressive relationship between progesterone receptor (PR) expression levels on breast cancer tissue and the IHC staining intensity for CR3—the higher the PR levels, the higher the CR3 expression (“p” = 0.004) (Figure 5F).